# Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis

> **NCT05065905** · PHASE1,PHASE2 · COMPLETED · sponsor: **SPP Pharmaclon Ltd.** · enrollment: 78 (actual)

## Conditions studied

- HIV Coinfection
- Aids/Hiv Problem
- Tuberculosis, Pulmonary
- Human Immunodeficiency Virus
- Lentivirus Infections
- RNA Virus Infections

## Interventions

- **DRUG:** Interferon-Gamma

## Key facts

- **NCT ID:** NCT05065905
- **Lead sponsor:** SPP Pharmaclon Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01-19
- **Primary completion:** 2006-03-29
- **Final completion:** 2006-04-06
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2024-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05065905

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05065905, "Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05065905. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*